Avava is a Pioneer precision skin therapy to improve the quality of life for patients around the world.
Avava has raised $19.6M in total funding. The most recent round was Series D. The last funding was announced in March 2026.
Avava's investors include Catalio Capital Management, Jeisys Medical.
Avava is headquartered in Waltham, United States.
Avava is a Pioneer precision skin therapy to improve the quality of life for patients around the world.
Avava is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avava — Funding & Investors." VCBacked, March 3, 2026, https://www.vcbacked.co/company/avava. Accessed September 30, 2026.
VCBacked. (2026). Avava — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/avava
{{cite web |title=Avava — Funding & Investors |url=https://www.vcbacked.co/company/avava |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated